Cracking the Code: Unraveling Charcot-Marie-Tooth Disease, Type I Through Genetic Testing
Uncover Charcot-Marie-Tooth Disease Type I with genetic testing. Gain precise diagnosis, guide family planning, and tailor treatment for improved patient care.
Dr. Brandon Colby, MD
MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
About
About Brandon
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
Education
- MD, Mount Sinai School of Medicine
- MBA, Stanford University Graduate School of Business
- BS in Genetics, with Honors, University of Michigan
Affiliations & Memberships
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Charting the Course of Chilblain Lupus: The Role of Genetic Testing in Diagnosis and Treatment
Genetic testing aids in diagnosing chilblain lupus, offering personalized treatment, risk assessment, and insights into novel therapies for enhanced patient care.
Challenging Cholesteryl Ester Storage Disease: The Role of Genetic Testing
Unlock the potential of genetic testing in diagnosing and managing cholesteryl ester storage disease. Learn about early detection, personalized treatment, and family planning.
Cracking the Code: Genetic Testing for Cockayne Syndrome Type 1
Explore how genetic testing aids in diagnosing Cockayne Syndrome Type 1, offering early diagnosis, personalized treatments, and crucial family planning insights.
Understanding Cockayne Syndrome Type 2: Genetic Testing as a Beacon of Hope
Explore how genetic testing helps diagnose and manage Cockayne Syndrome Type 2, a rare neurodegenerative disorder, by identifying specific DNA repair gene mutations.
Cracking the Code: Genetic Testing for Congenital Aniridia
Unlock personalized treatment for congenital aniridia. Genetic testing aids early diagnosis, family planning, and tailored care, improving vision and quality of life.
Comprehending Congenital Dyserythropoietic Anemia: The Role of Genetic Testing
Uncover how genetic testing enhances congenital dyserythropoietic anemia diagnosis, enabling personalized treatments and informed family planning strategies.
Congenital Long QT Syndrome: The Role of Genetic Testing in Understanding This Heart Disorder
Explore how genetic testing aids in diagnosing Long QT Syndrome, offering insights for at-risk individuals, personalized treatments, and informed family planning.